FDA Approval Of Repatha Cholesterol Drug A Big Win For Amgen New drug works differently from statins to lower 'bad' LDL cholesterol. Approval could bring billions into Amgen's coffers. by Jim Algar
Healthy Living/Wellness Sanofi, Regeneron experimental drug lowers risk of stroke, heart attack by Dianne Depra